Impact of the H1N1 Influenza A virus epidemic on cancer treatment in Hyogo, Japan
AbstractThe rapid spread of H1N1 influenza infection had impacts on healthcare systems. However, the impact on cancer treatment remains unknown. We sent questionnaires to 14 hospitals designated by the government as cancer treatment facilities in Hyogo and collected the following data: characteristics of hospitals, the number of cancer surgeries performed, establishment of specialized departments to treat H1N1 influenza patients, and the number of cancellations and postponements of surgeries. The study period was divided into three stages; the period from March 28 to May 15, 2009 as the pre-epidemic stage, that from May 16 to June 5 as the epidemic stage, and that from June 6 to July 3 as the post-epidemic stage. We compared the data collected during the three periods to investigate the influence of H1N1 influenza epidemic on cancer treatment. We received responses from 11 (78.6%) hospitals. Of these, 10 were general hospitals with more than 300 beds and 1 was a cancer centre. Of the 11 hospitals, 7 (68.4%) had established specialized departments to treat H1N1 influenza patients. Six hospitals had only outpatient departments and 1 had an outpatient department and an inpatient department. In 5 hospitals, surgeons were engaged in the treatment of H1N1 influenza patients. The number of cancellations or postponements in the pre-epidemic, epidemic and post-epidemic stage was 16, 10 and 7, respectively. No significant difference was found among the three periods in cancellation rate. H1N1 influenza epidemic did not directly influence the cancellation or postponement of performed for cancer patients. The impact of H1N1 influenza epidemic on the number of cancer surgeries performed was minimal.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.